Andra AP-fonden’s Charles River Laboratories CRL Stock Holding History

Andra AP-fonden’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,800	Closed	-$552K	–	404
2024 Q3	$552K	Sell	2,800 -8,100	-74%	-$1.68M	0.01%	390
2024 Q2	$2.25M	Sell	10,900 -300	-3%	-$68K	0.04%	347
2024 Q1	$3.03M	Buy	+11,200	New	+$2.67M	0.05%	312
2023 Q3	–	Sell	-8,100	Closed	-$1.7M	–	333
2023 Q2	$1.7M	Buy	8,100 +5,800	+252%	+$1.15M	0.04%	542
2023 Q1	$464K	Buy	+2,300	New	+$521K	0.01%	550
2022 Q3	–	Sell	-9,500	Closed	-$2.03M	–	562
2022 Q2	$2.03M	Buy	+9,500	New	+$2.32M	0.06%	504
2021 Q4	$1.77M	Sell	4,700 -2,300	-33%	-$894K	0.04%	514
2021 Q3	$2.89M	Buy	7,000 +1,400	+25%	+$581K	0.06%	525
2021 Q2	$2.07M	Buy	+5,600	New	+$1.87M	0.04%	557

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Andra AP-fonden's CRL Position: Q4 2024 in Review

Andra AP-fonden sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 2,800 shares — an estimated $552K sold.

Andra AP-fonden first reported a position in CRL in Q2 2021 and held it in 9 quarters. The position peaked at $3.03M in Q1 2024. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

Andra AP-fonden reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
Andra AP-fonden sold 2,800 Charles River Laboratories shares in Q4 2024, an estimated $552K.
Andra AP-fonden first reported a position in Charles River Laboratories in Q2 2021 and held it in 9 quarters.
Andra AP-fonden's Charles River Laboratories position peaked at $3.03M in Q1 2024.
637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Andra AP-fonden's 13F filing for Q4 2024, filed 7 Feb 2025.